Interpace Biosciences, Inc. (IDXG)
USD 1.0
(0.0%)
USD 1.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.22 Million USD | 0.25% |
| 2022 | 1.22 Million USD | -31.47% |
| 2021 | 1.78 Million USD | -12.96% |
| 2020 | 2.05 Million USD | 12.44% |
| 2019 | 1.82 Million USD | 48.37% |
| 2018 | 1.23 Million USD | 362.41% |
| 2017 | 266 Thousand USD | 1800.0% |
| 2016 | 14 Thousand USD | -99.75% |
| 2015 | 5.55 Million USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | -100.0% |
| 2012 | 92 Thousand USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 100.0% |
| 2009 | -18.63 Million USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | -100.0% |
| 2005 | 6.29 Million USD | 89.23% |
| 2004 | 3.32 Million USD | 7632.56% |
| 2003 | 43 Thousand USD | -93.34% |
| 2002 | 646 Thousand USD | 46.15% |
| 2001 | 442 Thousand USD | -98.79% |
| 2000 | 36.38 Million USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 1.15 Million USD | -5.95% |
| 2024 Q2 | 1.23 Million USD | 6.67% |
| 2023 FY | 1.22 Million USD | 0.25% |
| 2023 Q1 | 1.17 Million USD | -4.08% |
| 2023 Q3 | 1.09 Million USD | -7.14% |
| 2023 Q2 | 1.17 Million USD | 0.26% |
| 2023 Q4 | 1.22 Million USD | 12.26% |
| 2022 FY | 1.22 Million USD | -31.47% |
| 2022 Q2 | 2 Million USD | -2.53% |
| 2022 Q1 | 2.05 Million USD | 15.29% |
| 2022 Q3 | 1.24 Million USD | -37.92% |
| 2022 Q4 | 1.22 Million USD | -1.77% |
| 2021 Q4 | 1.78 Million USD | -21.36% |
| 2021 Q2 | 2.26 Million USD | 1.53% |
| 2021 Q3 | 2.27 Million USD | 0.44% |
| 2021 FY | 1.78 Million USD | -12.96% |
| 2021 Q1 | 2.22 Million USD | 8.53% |
| 2020 Q4 | 2.05 Million USD | -15.31% |
| 2020 Q3 | 2.42 Million USD | 3.95% |
| 2020 FY | 2.05 Million USD | 12.44% |
| 2020 Q1 | 1.88 Million USD | 3.29% |
| 2020 Q2 | 2.33 Million USD | 23.66% |
| 2019 Q2 | 1.04 Million USD | 10.52% |
| 2019 Q4 | 1.82 Million USD | -31.05% |
| 2019 Q1 | 941 Thousand USD | -23.5% |
| 2019 Q3 | 2.64 Million USD | 154.52% |
| 2019 FY | 1.82 Million USD | 48.37% |
| 2018 Q3 | 662 Thousand USD | 19.06% |
| 2018 FY | 1.23 Million USD | 362.41% |
| 2018 Q1 | 177 Thousand USD | -33.46% |
| 2018 Q2 | 556 Thousand USD | 214.12% |
| 2018 Q4 | 1.23 Million USD | 85.8% |
| 2017 FY | 266 Thousand USD | 1800.0% |
| 2017 Q1 | - USD | -100.0% |
| 2017 Q3 | - USD | -100.0% |
| 2017 Q2 | 1.00 USD | 0.0% |
| 2017 Q4 | 266 Thousand USD | 0.0% |
| 2016 Q4 | 14 Thousand USD | -90.67% |
| 2016 FY | 14 Thousand USD | -99.75% |
| 2016 Q3 | 150 Thousand USD | -84.68% |
| 2016 Q2 | 979 Thousand USD | -44.78% |
| 2016 Q1 | 1.77 Million USD | -68.08% |
| 2015 Q2 | 1.00 USD | 0.0% |
| 2015 Q3 | - USD | -100.0% |
| 2015 Q4 | 5.55 Million USD | 0.0% |
| 2015 FY | 5.55 Million USD | 0.0% |
| 2015 Q1 | 1.00 USD | 0.0% |
| 2014 Q1 | 1.00 USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | -100.0% |
| 2013 Q1 | 2.00 USD | -100.0% |
| 2013 FY | - USD | -100.0% |
| 2013 Q2 | 1.00 USD | -50.0% |
| 2013 Q4 | - USD | -100.0% |
| 2013 Q3 | 1.00 USD | 0.0% |
| 2012 Q4 | 92 Thousand USD | 0.0% |
| 2012 FY | 92 Thousand USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2010 FY | - USD | 100.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | -18.63 Million USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 FY | - USD | -100.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q1 | - USD | -100.0% |
| 2005 FY | 6.29 Million USD | 89.23% |
| 2005 Q4 | 6.29 Million USD | 49.17% |
| 2005 Q3 | 4.21 Million USD | -9.31% |
| 2005 Q2 | 4.65 Million USD | -42.35% |
| 2005 Q1 | 8.06 Million USD | 142.62% |
| 2004 Q4 | 3.32 Million USD | -14.74% |
| 2004 Q3 | 3.9 Million USD | -42.93% |
| 2004 Q2 | 6.83 Million USD | -38.13% |
| 2004 Q1 | 11.04 Million USD | 25588.37% |
| 2004 FY | 3.32 Million USD | 7632.56% |
| 2003 Q4 | 43 Thousand USD | -75.29% |
| 2003 Q2 | 1.06 Million USD | 10.27% |
| 2003 FY | 43 Thousand USD | -93.34% |
| 2003 Q1 | 964 Thousand USD | 49.23% |
| 2003 Q3 | 174 Thousand USD | -83.63% |
| 2002 Q2 | 24.04 Million USD | 0.0% |
| 2002 Q1 | 24.04 Million USD | 5339.14% |
| 2002 FY | 646 Thousand USD | 46.15% |
| 2002 Q4 | 646 Thousand USD | -97.31% |
| 2002 Q3 | 24.04 Million USD | 0.0% |
| 2001 Q2 | 70.28 Million USD | 39.76% |
| 2001 FY | 442 Thousand USD | -98.79% |
| 2001 Q4 | 442 Thousand USD | -99.51% |
| 2001 Q1 | 50.28 Million USD | 38.21% |
| 2001 Q3 | 91.02 Million USD | 29.51% |
| 2000 Q4 | 36.38 Million USD | 0.0% |
| 2000 FY | 36.38 Million USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Bio Medica Corporation | 379 Thousand USD | -223.747% |
| Arrayit Corporation | 464.19 Thousand USD | -164.33% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 757 Thousand USD | -62.087% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | -2385.00 USD | 51546.541% |
| DermTech, Inc. | 1 Million USD | -22.211% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 3.29 Million USD | 62.808% |
| HTG Molecular Diagnostics, Inc. | 909.32 Thousand USD | -34.935% |
| iMD Companies, Inc. | 38.31 Thousand USD | -3102.318% |
| IDenta Corp. | 442.28 Thousand USD | -177.425% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 163.13 Thousand USD | -652.138% |
| Lumos Diagnostics Holdings Limited | 784 Thousand USD | -56.505% |
| Many Bright Ideas Technologies Inc. | -375.00 USD | 327300.0% |
| Medical Imaging Corp. | - USD | -Infinity% |
| NovelStem International Corp. | - USD | -Infinity% |
| Optigenex Inc. | 468.77 Thousand USD | -161.747% |
| PharmChem, Inc. | 391.93 Thousand USD | -213.061% |
| Proteome Sciences plc | 1.06 Million USD | -15.157% |
| Response Genetics, Inc | 133 Thousand USD | -822.556% |
| Rennova Health, Inc. | 242.64 Thousand USD | -405.677% |
| RushNet, Inc. | - USD | -Infinity% |
| ScreenPro Security Inc. | 73.89 Thousand USD | -1560.419% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 95.62 Thousand USD | -1183.191% |
| Todos Medical Ltd. | 1.02 Million USD | -20.176% |